Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2017Hematological OncologyOpen Access

The 2016 updated WHO classification of lymphoid neoplasias

View Full Paper
Ask AI
Bookmark
Share

Authors

LQLeticia Quintanilla‐MartínezUniversity Children's Hospital Tübingen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Leticia Quintanilla‐Martínez (2017) studied this question.

synapsesocial.com/papers/6aa55f335becb0bc28eebc1chttps://doi.org/10.1002/hon.2399
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The 2016 revision of the World Health Organization classification of lymphoid neoplasms2016 · 7,961 citations
  2. 2MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program2013 · 684 citations
  3. 3Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab2010 · 484 citations
  4. 4Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma2013 · 173 citations
  5. 5ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes2014 · 477 citations